Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Chronic Kidney Disease in France, Based on the EMPA-KIDNEY Clinical Trial
Clinical Drug Investigation · 2024-11 · 44 (11) · 811-828
DOI: 10.1007/s40261-024-01398-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Drug Investigation, online erschienen am 24.10.2024. Verfasst von Harinala Groyer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Boehringer Ingelheim, Paris, France. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Glucosides, Cost-Benefit Analysis, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Boehringer Ingelheim France.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Boehringer Ingelheim, Paris, France.
- Putnam, Paris, France. romain.supiot@putassoc.com.
- Putnam, Paris, France.
- Université Paris-Dauphine, Université PSL, LEDa (LEGOS), Paris, France.
- Boehringer Ingelheim International GmbH, Ingelheim, Germany.
- Paris and Department of Nephrology, Association Pour l'Utilisation du Rein Artificiel (AURA), Ambroise Paré University Medical Center, APHP, Paris, France.
Förderung
- Boehringer Ingelheim France
Zitieren
APA
Groyer, H., Supiot, R., Tardu, J., Virely, N., Sivignon, M., San, D., Lévy, P., Ustyugova, A., & Massy, Z. A. (2024). Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Chronic Kidney Disease in France, Based on the EMPA-KIDNEY Clinical Trial. Clinical Drug Investigation, 44(11), 811-828. https://doi.org/10.1007/s40261-024-01398-4
Vancouver
Groyer H, Supiot R, Tardu J, Virely N, Sivignon M, San D, et al. Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Chronic Kidney Disease in France, Based on the EMPA-KIDNEY Clinical Trial. Clinical Drug Investigation. 2024;44(11):811-828. doi:10.1007/s40261-024-01398-4
BibTeX
@article{Groyer2024,
author = {Groyer, Harinala and Supiot, Romain and Tardu, Jean and Virely, Nicolas and Sivignon, Marine and San, Denis and Lévy, Pierre and Ustyugova, Anastasia and Massy, Ziad A},
title = {Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Chronic Kidney Disease in France, Based on the EMPA-KIDNEY Clinical Trial},
journal = {Clinical Drug Investigation},
year = {2024},
volume = {44},
number = {11},
pages = {811--828},
doi = {10.1007/s40261-024-01398-4}
}
EUVIMED